MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Operating cash flow 2021–2025
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$196.0MFY2025 · since FY2021: -$611,071 → -$196.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$196.0M | -68.1% |
| FY2024 | -$116.6M | -172.5% |
| FY2023 | -$42.8M | +23.5% |
| FY2022 | -$55.9M | -9046.9% |
| FY2021 | -$611,071 | — |
Source: SEC XBRL filings · For reference only · Not investment advice